Tests pre-surgery rehabilitation before limb sarcoma surgery
Tests a pre-operative rehabilitation program in people with limb sarcoma before surgery.
Plain-language title generated from the registry record
Registry title: Efficacy of Pre-operative Prehabilitation in Patients With Limb Sarcoma
Key facts
- Where
- Toulouse, FranceSee the site
- Phase
- Phase 2
Where in France
- Institut Universitaire du Cancer de Toulouse - OncopoleToulouse, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Institut Claudius Regaud
- Trial code
- NCT04515459
- Record updated
- 15 September 2025
- Original description
This Phase II feasibility study, prospective, interventional, monocentric aiming to assess the interest of pre-operative rehabilitation in patients treated for bone or soft-tissue sarcoma of the limbs.Read full original descriptionShow less
Efficacy of Pre-operative Prehabilitation in Patients With Limb Sarcoma
This Phase II feasibility study, prospective, interventional, monocentric aiming to assess the interest of pre-operative rehabilitation in patients treated for bone or soft-tissue sarcoma of the limbs.
This protocol will be based on the realisation of a surgical prehabilitation program adapted to the patient. This strategy will involve a team of several health professionals: rehabilitation doctor, physiotherapist, occupational therapist, specialised nurse, dietician and adapted physical activity teacher.
The aim of an adapted surgical prehabilitation program is to improve the functional recovery of the treated limb and the patient's autonomy after surgery.
Each patient will be followed until 24 months post surgery.
Inclusion: Age > or = 16 years old; Patient with a diagnosis of bone or soft-tissue sarcoma confirmed by the "Réseau de Relecture en Pathologie Sarcomateuse (RRePS)"; Tumour localized in the lower or upper limb; Localized or metastatic disease (in case of metastatic disease, the optimal surgical treatment for the primary tumor must be performed); Indication of neoadjuvant treatment (radiotherapy and/or chemotherapy) according to the Multidisciplinary Concertation Meeting; Inclusion before the initiation or during neoadjuvant treatment. In both cases, surgery must be scheduled between 6 and 10 weeks after inclusion, to permit the completion of the surgical prehabilitation; Patient must provide written informed consent prior to any study-specific procedure. For minor patients, the holder(s) of parental authority must sign the informed consent and the patient's assent must be obtained; Patient affiliated to the French social security system.
Exclusion: Metastatic disease without optimal surgery planned of the primary tumour; Any disease or medical condition that could interfere with study procedure, or that could, according to the judgment of investigator, expose the patient to an unacceptable risk; Patient who has forfeited his/her freedom by administrative or legal award or who is under legal protection (curatorship and guardianship, protection of justice); Any psychological, familial, geographic or social situation preventing compliance with the medical monitoring and/or with study procedure; Pregnant or breastfeeding patient.